Download presentation
Presentation is loading. Please wait.
1
Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotens inconverting enzyme; ARB, angiotensin receptor blocker; CRT-D, cardiac resynchronization therapy defibrillator; CRT-P, cardiac resynchronization therapy pacemaker; H-ISDN, hydralazine and isosorbide dinitrate; HR, heart rate; ICD, implantable cardioverter defibrillator; LBBB, left bundle branch block; LVAD, left ventricular assist device; LVEF, left ventricular ejection fraction; MR antagonist, mineralocorticoid receptor antagonist; NYHA, New York Heart Association. (Modified, with permission, from McMurray JJ et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Eur J Heart Fail Aug;14(8):803–69. [PMID: ]) Source: Heart Disease, Current Medical Diagnosis & Treatment 2017 Citation: Papadakis MA, McPhee SJ, Rabow MW. Current Medical Diagnosis & Treatment 2017; 2016 Available at: Accessed: October 10, 2017 Copyright © 2017 McGraw-Hill Education. All rights reserved
![Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotens inconverting enzyme; ARB, angiotensin receptor blocker; CRT-D, cardiac resynchronization therapy defibrillator; CRT-P, cardiac resynchronization therapy pacemaker; H-ISDN, hydralazine and isosorbide dinitrate; HR, heart rate; ICD, implantable cardioverter defibrillator; LBBB, left bundle branch block; LVAD, left ventricular assist device; LVEF, left ventricular ejection fraction; MR antagonist, mineralocorticoid receptor antagonist; NYHA, New York Heart Association. (Modified, with permission, from McMurray JJ et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Eur J Heart Fail Aug;14(8):803–69. [PMID: ])](http://slideplayer.com/slide/12860027/78/images/1/Treatment+options+for+patients+with+chronic+symptomatic+systolic+heart+failure.+ACE%2C+angiotens+inconverting+enzyme%3B+ARB%2C+angiotensin+receptor+blocker%3B+CRT-D%2C+cardiac+resynchronization+therapy+defibrillator%3B+CRT-P%2C+cardiac+resynchronization+therapy+pacemaker%3B+H-ISDN%2C+hydralazine+and+isosorbide+dinitrate%3B+HR%2C+heart+rate%3B+ICD%2C+implantable+cardioverter+defibrillator%3B+LBBB%2C+left+bundle+branch+block%3B+LVAD%2C+left+ventricular+assist+device%3B+LVEF%2C+left+ventricular+ejection+fraction%3B+MR+antagonist%2C+mineralocorticoid+receptor+antagonist%3B+NYHA%2C+New+York+Heart+Association.+%28Modified%2C+with+permission%2C+from+McMurray+JJ+et+al.+ESC+guidelines+for+the+diagnosis+and+treatment+of+acute+and+chronic+heart+failure+2012%3A+the+Task+Force+for+the+Diagnosis+and+Treatment+of+Acute+and+Chronic+Heart+Failure+2012+of+the+European+Society+of+Cardiology.+Eur+J+Heart+Fail+Aug%3B14%288%29%3A803%E2%80%9369.+%5BPMID%3A+%5D%29.jpg "Source: Heart Disease, Current Medical Diagnosis & Treatment Citation: Papadakis MA, McPhee SJ, Rabow MW. Current Medical Diagnosis & Treatment 2017; 2016 Available at: image=/data/books/1843/cmdt17_ch10_f009.png&sec= &BookID=1843&ChapterSecID= &imagename= Accessed: October 10, Copyright © 2017 McGraw-Hill Education. All rights reserved.")
Similar presentations
![KOH preparation showing branched hyphae and budding yeast of Candida albicans. (Reproduced, with permission, from DeCherney AH, Pernoll ML [editors]. Current.](/79/12975400/big_thumb.jpg "KOH preparation showing branched hyphae and budding yeast of Candida albicans. (Reproduced, with permission, from DeCherney AH, Pernoll ML [editors]. Current.>")
